Spatial proteomics for the molecular characterization of breast cancer

K Brožová, B Hantusch, L Kenner, K Kratochwill - Proteomes, 2023 - mdpi.com
Breast cancer (BC) is a major global health issue, affecting a significant proportion of the
female population and contributing to high rates of mortality. One of the primary challenges …

Correlative multi-modal microscopy: a novel pipeline for optimizing fluorescence microscopy resolutions in biological applications

S Pelicci, L Furia, PG Pelicci, M Faretta - Cells, 2023 - mdpi.com
The modern fluorescence microscope is the convergence point of technologies with different
performances in terms of statistical sampling, number of simultaneously analyzed signals …

Recent advancements in tumour microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial …

MD Andhari, A Antoranz, F De Smet… - International Review of Cell …, 2024 - Elsevier
Immune checkpoint therapies have significantly advanced cancer treatment. Nevertheless,
the high costs and potential adverse effects associated with these therapies highlight the …

Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN

MM Bolognesi, A Antoranz, FM Bosisio… - Acta Neuropathologica …, 2023 - Springer
Cyclic multiplex immunostaining consists of cycles of staining, imaging, removal of the signal
and repetition with another set of antibodies. Removal of the primary and secondary …

A DNA damage response‐like phenotype defines a third of colon cancers at onset

S Mauro, MM Bolognesi, N Villa, G Capitoli… - The FASEB …, 2023 - Wiley Online Library
Colon adenocarcinoma (COAD) has a limited range of diversified, personalized therapeutic
opportunities, besides DNA hypermutating cases; thus, both new targets or broadening …

Seeing or believing in hyperplexed spatial proteomics via antibodies: New and old biases for an image-based technology

MM Bolognesi, L Dall'Olio, A Maerten, S Borghesi… - Biological …, 2024 - cambridge.org
Hyperplexed in-situ targeted proteomics via antibody immunodetection (ie,> 15 markers) is
changing how we classify cells and tissues. Differently from other high-dimensional single …